Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8911996rdf:typepubmed:Citationlld:pubmed
pubmed-article:8911996lifeskim:mentionsumls-concept:C1257890lld:lifeskim
pubmed-article:8911996lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:8911996lifeskim:mentionsumls-concept:C0011854lld:lifeskim
pubmed-article:8911996lifeskim:mentionsumls-concept:C0231335lld:lifeskim
pubmed-article:8911996lifeskim:mentionsumls-concept:C0017337lld:lifeskim
pubmed-article:8911996lifeskim:mentionsumls-concept:C0063710lld:lifeskim
pubmed-article:8911996lifeskim:mentionsumls-concept:C0011847lld:lifeskim
pubmed-article:8911996lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:8911996lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:8911996lifeskim:mentionsumls-concept:C0016132lld:lifeskim
pubmed-article:8911996pubmed:issue1lld:pubmed
pubmed-article:8911996pubmed:dateCreated1997-2-13lld:pubmed
pubmed-article:8911996pubmed:abstractTextThe polygenic susceptibility to type 1 diabetes is well established and recent studies have demonstrated linkage of a further locus on chromosome 2q to disease. We have studied a polymorphism of the interleukin-1 receptor type 1 gene (IL1R1) on chromosome 2q in type 1 diabetic and control subjects from Finland, the United Kingdom, South India: three populations in which the risk of disease varies from very high to very low. In the medium-risk U.K. population we find a very strong association of IL1R1 with type 1 diabetes (p = 0.0002) but we find no overall association in either the high-risk Finnish or low-risk South-Indian populations. However, we do find heterogeneity of risk at IL1R1 amongst Finnish diabetic subjects according to the possession of HLA-DR associated susceptibility (p = 0.0001); there is an association with IL1R1 in only those Finnish diabetic subjects who do not possess high-risk HLA-DR4 or DR3 haplotypes (p = 0.006), as recently demonstrated for the insulin gene region in this population. We find no such heterogeneity of risk in either the U.K. or South-Indian populations. This study further demonstrates the genetic heterogeneity of disease susceptibility between and within populations and also supports the hypothesis of an interaction of the IL1R1 locus with genes within the HLA and insulin gene regions in the susceptibility to type 1 diabetes.lld:pubmed
pubmed-article:8911996pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8911996pubmed:languageenglld:pubmed
pubmed-article:8911996pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8911996pubmed:citationSubsetIMlld:pubmed
pubmed-article:8911996pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8911996pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8911996pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8911996pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8911996pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8911996pubmed:statusMEDLINElld:pubmed
pubmed-article:8911996pubmed:monthNovlld:pubmed
pubmed-article:8911996pubmed:issn0198-8859lld:pubmed
pubmed-article:8911996pubmed:authorpubmed-author:TuomilehtoJJlld:pubmed
pubmed-article:8911996pubmed:authorpubmed-author:NerupJJlld:pubmed
pubmed-article:8911996pubmed:authorpubmed-author:ViswanathanMMlld:pubmed
pubmed-article:8911996pubmed:authorpubmed-author:RamachandranA...lld:pubmed
pubmed-article:8911996pubmed:authorpubmed-author:HitmanG AGAlld:pubmed
pubmed-article:8911996pubmed:authorpubmed-author:Tuomilehto-Wo...lld:pubmed
pubmed-article:8911996pubmed:authorpubmed-author:PociotFFlld:pubmed
pubmed-article:8911996pubmed:authorpubmed-author:BergholdtRRlld:pubmed
pubmed-article:8911996pubmed:authorpubmed-author:MetcalfeK AKAlld:pubmed
pubmed-article:8911996pubmed:issnTypePrintlld:pubmed
pubmed-article:8911996pubmed:volume51lld:pubmed
pubmed-article:8911996pubmed:ownerNLMlld:pubmed
pubmed-article:8911996pubmed:authorsCompleteYlld:pubmed
pubmed-article:8911996pubmed:pagination41-8lld:pubmed
pubmed-article:8911996pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:8911996pubmed:meshHeadingpubmed-meshheading:8911996-...lld:pubmed
pubmed-article:8911996pubmed:meshHeadingpubmed-meshheading:8911996-...lld:pubmed
pubmed-article:8911996pubmed:meshHeadingpubmed-meshheading:8911996-...lld:pubmed
pubmed-article:8911996pubmed:meshHeadingpubmed-meshheading:8911996-...lld:pubmed
pubmed-article:8911996pubmed:meshHeadingpubmed-meshheading:8911996-...lld:pubmed
pubmed-article:8911996pubmed:meshHeadingpubmed-meshheading:8911996-...lld:pubmed
pubmed-article:8911996pubmed:meshHeadingpubmed-meshheading:8911996-...lld:pubmed
pubmed-article:8911996pubmed:meshHeadingpubmed-meshheading:8911996-...lld:pubmed
pubmed-article:8911996pubmed:meshHeadingpubmed-meshheading:8911996-...lld:pubmed
pubmed-article:8911996pubmed:meshHeadingpubmed-meshheading:8911996-...lld:pubmed
pubmed-article:8911996pubmed:meshHeadingpubmed-meshheading:8911996-...lld:pubmed
pubmed-article:8911996pubmed:meshHeadingpubmed-meshheading:8911996-...lld:pubmed
pubmed-article:8911996pubmed:year1996lld:pubmed
pubmed-article:8911996pubmed:articleTitleAn association between type 1 diabetes and the interleukin-1 receptor type 1 gene. The DiMe Study Group. Childhood Diabetes in Finland.lld:pubmed
pubmed-article:8911996pubmed:affiliationCellular Mechanisms Research Group, Medical Unit, Royal London Hospital, Whitechapel, United Kingdom.lld:pubmed
pubmed-article:8911996pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8911996pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:8911996pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:25663entrezgene:pubmedpubmed-article:8911996lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8911996lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8911996lld:pubmed